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1 Introduction
The increasing interest to reduce perinatal morbi-
mortality rates has stimulated the search for ade-
quate and effective methods for assessing fetal
growth and wellbeing in high risk pregnancies.
Several biochemical, biophysical and clinical
methods have been suggested to allow a better
evaluation of the fetus.
Good fetal vitality will result in a vigorous neonate
with an adequate birthweight. This will depend
on good placental function, normal fetal growth
and the presence or absence of fetal distress.
With the aim of obtaining reliable fetal growth
indicators, the following determinations have been
performed:
1. Human chorionic somatomammotropic hör-
mone (hCS) which reflects the trophoblast
endocrine functions [24] and may play a role
in fetal growth [26].
2. Estriol, synthetized by the feto-placental unit
[5], the levels of which reflect fetal adrenal and
placental functions and the metäbolic ex-
change between fetal and placental compart-
ments.
3. Oxytocinase. The maternal levels of this en-
zyme, produced by the sincitiotrophoblast,
may reflect functional placental mass [13].
2 Material and Methods
A group of 56 women with high risk pregnancies
were studiedsincethe 32nd week of gestation. The
associated maternal diseases are shown in Tab. I.
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The cases with arterial hypertension were those
with diastolic blood pressure of 90 mm Hg or
higher. Diabetic patients were classified according
toWHITE[30].
When patients were Rh (-) and had a positive ag-
glutinin title they were considered Rh isoimmun-
ization.
In the group of other diseases were included
patients with cardiac disease, urinary infection,
intrauterine growth retardation and epilepsy.
Serum hCS, estriol and Oxytocinase levels were
compared among the different maternal groups.
The variance analysis did not show statistical
differences between these diseases.
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Tab. 1.56 womenwith high risk pregnancies. Studied since
the 32nd week of gestation with the associated maternal
diseases.
Maternal Diseases hCS Estriol Oxyto-
cinase
Hypertension 7
Diabetes B and C 7
Diabetes D-F-R 4
Diabetes + Hyper-
tension 3
Rh isoimmuni-
zation 10
Rh isoimmuni-
zation + Hyper-
tension l
Rh isoimmuni-
zation + Diabetes 2
Other diseases 22
7
7
4
4
9
l
2
21
6
6
4
4
8
0
l
13
TOTAL 56 55 42
Patients who had received drugs (e.g. ampicillin,
nitrofiirane, sulfamides, corticoids, etc.) that
could alter hormonal levels, were not included in
this study.
In all patients, three blood samples were obtained
weekly, at the same time (11:30 to 12:00 am) to
avoid circadian variations. The serum was separated
and kept at -20 °C until it was processed. Only
the average value of the three samples obtained
in the week preceding delivery was considered for
this study.
hCS was determined by a specific RIA with com-
mercialkits[16]*.
Immunoreactive estriol was determined by RIA in
unextracted serum. Commercial kits were used
[9]**.
* HPL Immunoassay Kit Code IM. 68
Amersham, 2636 S. Clearbrook Drive, Arlington Heights
111. 60005, EE.UU.
** Estriol Serum (extracted or direct) and urineRIA test
kit. Nuclear Medical Systems, Inc., 1531, Monrovia Ave.,
Newport Beach, CA 92663, EE. UU.
Oxytocinase activity was determined by a colori-
metric method, using L-cystine-di-B-naftilamide
äs Substrate [29].
All newborns were weighed using the same scale
and during the first hour of life. Gestational age
was calculated by weeks of amenorrhea and
confirmed by the score of CAPURRO [2].
Newborns were considered small for date when
their weight was below the lOth percentile of the
local growth curve [3] (Fig. 1).
The newborns were classified into two groups,
small for date and adequate weight for gestational
age. The mean gestational agejn the small for date
group was 268 ± 13.7 days (X ± l SD) and in the
adequate weight group, 274.3 ± 14.4 days (X ±
l SD). The difference between both groups was
not statistically significant (t test).
3 Results
3.1 hCS, estriol and oxytocinase levels related
with birihweight.
The mean level of hCS obtained during the week
preceding delivery was correlated with the weight
of the newborns. There was a weak association
between both variables (r = 030, p <0.05) (Fig. 2).
Serum estriol levels obtained in 55 pregnancies
were correlated with the weight of the newborns.
O ARTERIAL HYPERTENSION
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Fig. 1. Local growth curve percentiles 10, 50 and 90. AU
neonates are plotted according to materjial disease.
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Fig. 2. Correlation between mean maternal hCS during
the week before delivery and neonatal birthwejght in
high risk pregnancies.
A weak correlation was found (r = 0.33, p < 0.01)
(Fig. 3).
Oxytocinase levels were determined only in 42
patients. The correlation between these levels and
birthweight was weak (r = 0.30, p < 0.05) (Fig. 4).
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Fig. 3. Correlation between mean maternal serum estriol
during the week before delivery and neonatal birthweight
in high risk pregnancies.
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Fig. 4. Correlation between mean maternal serum oxyto-
cinase during the week before delivery and neonatal birth-
weight in high risk pregnancies.
3.2 hCS, estriol and Oxytocinase levels according
to birthweight (small for date and adequate
weight).
hCS. Maternal hCS level corresponding to 42 new-
borns with adequate birthweight for their gestatio-
nal age was 7.94 ± 3.98 ug/ml (X ± l SD). This
value was statistically higher (t test, p < 0.05)
than the corresponding to the group of 14 small
for date newborns, which was 5.15 ± 2.11 ug/ml
(X± l SD) (Fig. 5).
Based on this difference, a critical level of 7 ug/ml
was arbitrarily established. In 12 of 33 pregnancies
(36.4%) with levels of 7 ug/ml or less of hCS in
serum, newborns were small for their gestational
age.
On the other hand, when serum hCS level was
higher than 7 ug/ml, only 2 of 23 newborns (8.7%)
were small for date.
The difference between both groups was statistic-
ally significant (FISHER test, p = 0.015) (Fig. 6).
Estriol. The mean value of maternal estriol in
serum was compared between 37 adequate weight
newborns (42.38 ± 18.55 ng/ml) and 14 small for
dates (29.24 ± 16.75 ng/ml). A statistically signif-
icant difference was found between both groups
(t test, p < 0.05) (Fig. 7).
•p<0.05
Fig. 5. Mean maternal hCS values obtained the week be-
fore delivery for both groups, small-for-date and adequate
weight neonates.
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date. On the other hand, when the serum estriol
level was more than 35 ng/ml, only 5 of 28 neo-
nates (17.9%) were small for dates.
This difference was not statistica y significant
I TH WEIGHT FOR (F HER test, p = 0.06) (Fig. 8).
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Oxytocinase. A similar analysis between both
groups of adequate weight and small for date
neonates was performed with the mean level of
Oxytocinase. There was no statistically significant
difference (t test, p > 0.05). However, oxyto-
cinase levels were higher in the group of mothers
with adequate weight newborns (7.10 ± 2.53 mg
B-naftflamide/100 ml/hr) than in the group of
mothers with small for date neonates (5.74 ±
2.41 mg B-naft amide/100 ml/hr).
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Fig. 6. Relative frequency of neonates classified according
to biithweight for the gestational age and to critical value
of maternal serum hCS.
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3.3 hCS and estriol studied jointly s indicators
of possible newborn weight (small for date or
adequate weight).
Critical hCS and serum estriol levels were considered
jointly (7 ug/ml and 35 ng/ml respectively). Neo-
nates were divided into two groups: One group
from mothers with both hormones below the cri-
tical levels, and the other from mothers in whom
both values were above this level.
In the group of mothers with levels below the
critical value, 8 of 13 neonates (615%) were small
n.23
O
Fig. 7. Mean maternal estriol values obtained the week
before delivery for both groups, small-for-date and ad-
equate weight neonates.
Based on this difference, the arbitrary value of 35
ng/ml was established s critical level for serum
estriol.
In 9 of 23 pregnancies (39.1%) with serum estriol
of 35 ng/ml or less, the newborns were small for
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Fig. 8. Relative frequency of neonates classified according
to birthwejght for the gestational age and to the critical
vahie of maternal serum estriol.
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for date; on the other hand, when hormone levels
were above the critical level, only l of the 13 new-
borns (7.7%) was small for date. The difference
between both groups was statistically significant
(FISHER test, p = 0.005).
In 26 mothers in whom both hormone levels were
above or below criticalvalues, the correct prediction
of adequate weight or small for date was made in
20 (76.9%) (Fig. 9).
From the total number of 51 patients studied,
26 (51%) had both hCS and estriol levels either
above or below critical values. In 10 patients
(19.6%) hCS was above and estriol was below
n.13 n»13
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n»5
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Fig. 9, Neonate distribution according to the birthweight
for gestational age when critical levels of both hormone s
were considered concomitantly.
n· 13
critical values. In 15 pregnancies (29.4%) the
reverse Situation was found (Fig. 10).
4 Discussion
Several authors have found an association between
birth-weight and matemal serum levels of hCS,
estriol and oxytocinase [l, 8, 10, 11, 12, 14, 15,
16,17,18,20,21,22,23,25,28].
However, this association was not confirmed by
others [4, 6, 7, 19, 27]. Although we have found
statistically significant correlations between these
Parameters in our population, their dispersion was
considerable.
When we divided our newborns into two groups,
one of small for dates and the other with adequate
birthweight, maternal serum levels of hCS and
estriol were significantly lower in those with
small for date newborns. On the other hand, there
was no statistically significant difference when
only oxytocinase serum levels were studied.
A critical level of maternal serum hCS and estriol
was established according to the above results,
below which newborns would have a greater poss-
ibility of being small for date.
Approximately 30% of the newborns with mater-
nal hCS serum levels equal or lower than 7 ug/ml
were small for date. A similar incidence of small
for dates was observed when maternal serum estriol
levels were lower than 35 ng/n .
However, a greater proportion of false negatives
(18%) (small for dates with high hormonal levels)
n.9
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Fig. 10. Neonate distribution according to the birthweight for gestationai age considering that hCS and maternal estriol
levels were above or below critical values.
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was observed with estriol than with hCS, whose
incidence of false negatives was 8.7%.
When both hormones were considered simultan-
eously, in 50% of the patients, both levels were
either high or low. The prediction of birthweight
was correct in 77% of these cases (Fig. 9). Only
one of these 26 pregnant women (3.8%) had a
small for date newborn and higher than critical
matemal hormone levels. r
Summarizing, our results indicate that fetal growth
can be better predicted by the concomitant con-
sideration of hCS and estriol levels in matemal
serum than by studying each hormone separately.
5 Summary
A group of 56 women with high risk pregnancies were
studied since the 32nd week of gestation.
With the aim of obtaining reliable fetal growth indicators,
maternal serum hCS, estriol and oxytocinase levels were
determined. hCS and estriol were determined by specific
radioimmunoassays and oxytocinase with a colorimetric
ipethod.
Meän values obtained the week before delivery öf both
hormones and the enzyme were correlated with the weight
of the newborns. The correlation coefficients were 0.30,
0.33 and 030 for hCS, estriol and oxytocinase respectively
(Figs.2,3and4).
The newborns were classified into two groups, small for
date and adequate weight for gestational age. Maternal
hCS level corresponding to newborns with adequate
birthweight for their gestational age was 7.94 ug/ml. This
value was statistically higher than that corresponding to
the group of smäll-for-date newborns, which was 5.15
ug/ml (Fig. 5).
Similar results were obtained when the maternal estriol
levels were considered according to the birthweight (Fig.
7). The same analysis applied to oxytocinase values did
not show statistically significant differences.
Arbitrary critical levels were estäblished for hCS and
estriol at 7 ug/ml and 35 ng/ml respectively. When values
were below these levels, newborns would have greater
possibility of being small for dates (Figs. 6 and 8).
The predictive value was best when both hormones were
considered concomitantly (77%) (Fig. 9). These results
indicate the suitability of considering hCS and estriol
levels in order to assess fetal growth.
Keywords: Adequate-weight newborn, fetal growth, high risk pregnancies, serum estriol, serum hCS, serum oxytocinase,
small-for-date newborn.
Zusammenfassung
HCS, Östriol und Oxytozinase als Indices des fetalen
Wachstums.
Eine Gruppe von 56 Risikoschwangeren wurden seit der
32. Schwangerschaftswoche beobachtet. Mit dem Ziel,
zuverlässige fetale Wachstums-indikatoren zu erhalten,
wurden HCS, Östriol und Oxytozinase im Serum be-
stimmt. HCS und Östriol wurden durch spezifische
Radioimmunoassays und Oxytozinase durch eine kolori-
metrische Methode bestimmt.
Die in der Woche vor der Entbindung erhaltenen Mittel-
werte von beiden Hormonen und dem Enzym wurden zu
dem Gewicht der Neugeborenen in Beziehung gebracht.
Die Korrelations-Koeffizienten waren 0.30, 0.33 und
0.30 für das HCS, Östriol und Oxytozinase (s. Abb. 2, 3
und 4).
Die Neugeborenen wurden in zwei Gruppen eingeteilt: die
Untergewichtigen und die Normalgewichtigen gemäß ihres
Schwangerschaftsalters. Der mütterliche HCS-Spiegel in
der Gruppe der Neugeborenen mit normalem Geburtsge-
wicht gemäß ihrer Schwangerschaftszeit war 7,94 Mg/ml.
Dieser Wert war statistisch höher als der entsprechende
der Gruppe der untergewichtigen Neugeborenen, dieser
betrug 5,15 Mg/ml. Dieser Wert war statistisch höher als
der entsprechende der Gruppe der untergewichtigen Neu-
geborenen, dieser betrug 5,15 Mg/ml (Abb. 5)
Ähnliche Werte wurden erhalten, wenn die mütterlichen
Östriol-Spiegel gemäß dem Geburtsgewicht berücksich-
tigt wurden (Abb. 7). Die Analyse der Oxytozinase-Werte
ergaben keine statistisch bemerkenswerten Differenzen.
Willkürlich festgelegte Grenzwerte waren für HCS und
Östriol 7 Mg/ml und 35 ng/ml. Wenn die Werte niedriger
als diese Spiegel waren, war bei den Neugeborenen die
Möglichkeit der Untergewichtigkeit größer (Abb. 6 und
8).
Der Aussagewert war der beste, wenn beide Hormone
gleichzeitig berücksichtigt wurden (77%) (Abb. 9). Diese
Ergebnisse zeigen die Eignung der HCS- und Östriol-Be-
stimmung zur Voraussage des fetalen Wachstums.
Schlüsselwörter: Fetales Wachstum, HCS, Neugeborenes, Östriol, Oxytozinase, Risikoschwangerschaften, Untergewich-
tigkeit.
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Resume
La somatomammotropine chorionique humaine, Festriol
et Foxy tocinase comme indices de la croissance foetale
Un groupe de 56 femmes avec grossesse ä haut risque ont
fait l'objet d'examens a partir de la 32eme semaine de
gestation. £n vue d'obtenir des indicateurs sürs de crois-
sance foetale, nous avons determine les degres de somato-
mammotropine chorionique humaine, d'estriol et d'oxyto-
cinase du serum maternel. Les deux premiers ont ete
mesures par radioimmunoessais specifiques et la troisieme
par methode colorimetrique. Les valeurs moyennes ob-
tenues la semaine precedant a Faccouchement pour les
deux hormones et Fenzyme ont ete en correlation avec
le poids des nouveaux-nes. Les coefficients de correlation
ont ete respectivement de 0,30, 0,33 et 0,30 pour la seh,
Festriol et l'oxytocinase (fig. 2,3 et 4).
Les nouveaux-nes ont ete classes en deux groupes selon
qu'ils avaient du souspoids ou un poids conforme pour
Fäge gestationnel considere. Le degre de SCh maternelle
correspondant aux nouveaux-nes avec un poids de naiss-
ance normal pour leur äge gestationnel s'est chiffre a
7,94 Mg/ml. Cette valeur a ete statistiquement plus elevee
que celle correspondant au groupe des nouveaux-nes
immatures et qui n'a pas depasse 5,15 Mg/ml (fig. 5).
Des resultats similaires ont ete obtenus pour les degres
d'estriol maternel selon les divers poids de naissance
(fig. 7).
Par contre, la meme analyse appliquee a Foxy tocinase n'a
pas revele de differences statistiquement significatives.
Des degres critiques arbitraires ont ete fixes respectivement
pour la SCh et Festriol ä 7 Mg/ml et 35 Mg/ml. S'üs sont
inferieurs %a ces seuils, on observe une plus grande pro-
babilite d'immaturite pour les nouveaux-nes (fig. 6 et 8).
Le pronostic est le plus precis en cas d'evaluation simul-
tanee de ces deux hormones (77%) (fig. 9). On peut donc
recommander la mesure de la SCh et de Festriol si on veut
de terminer Fevolution de la croissance foetale.
Mots-cles: Croissance foetale, estriol du serum, grossesses a haut risque, nouveaux-nes de poids normal, nouveaux-nes
immatures, oxytocinase du serum, SCh.
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